SAMDI TECH, INC.
Biotech
Label-free cell-based assay platform using self-assembled monolayers (SAMs) on gold surfaces with MALDI mass spectrometry readout to quantitate specific enzyme activities in drug discovery
- Grants
- $2.4M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · The first cell-based and label-free, high-throughput assay of specific enzyme activities | $224,818 | |
| Federal grant | Department of Health and Human Services · Phase I · Traceless immobilization and SAMDI mass spectrometry enables high-throughput screening of any analyte. | $224,978 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of the first label-free and high-throughput, cell-based assay that reports on specific enzyme activities | $1,076,401 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of the first label-free and high-throughput, cell-based assay that reports on specific enzyme activities | $923,599 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2047 | BLR BIO, LLC | — | — |
| 2048 | KEYBIOME INC | — | — |
| 2049 | Seven Bridges Capital LLC | — | $1.0M |
| 2050 | SAMDI TECH, INC. | — | — |
| 2051 | CORD BLOOD PLUS, INC. | — | — |
| 2052 | ViraCyte LLC | — | — |
| 2053 | Tome Biosciences | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Articles And Methods Involving Detection Of Bindingapplication
- Articles And Methods Involving Detection Of Bindingapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.